Study guide
21.2 Medical information in credit decisions: Regulation FF and V
CRCM Certified Regulatory Compliance Manager Exam
Track your progress as you read
Finished sections get a check mark.
1 1. CRCM Exam and Study Planning
1.1 CRCM examination, eligibility and study strategy
2 2. Electronic Transfers and Error Intake
2.1 Regulation E: Coverage and Consumer Disclosures 2.2 Regulation E: Error Notices and Unauthorized Transfer Liability 2.3 EFT Error Investigation and Provisional Credit
3 3. EFT Investigations, Remittances and Prepaid Accounts
3.1 Extended Error Rules and Remittance Transfers 3.2 Prepaid accounts and special Regulation E controls 3.3 Truth in Savings: Account Disclosures and APY
4 4. Overdraft Operations and Advertising
4.1 Overdraft Practices, Fees and Advertised Terms
5 5. ECOA Applications and Credit Decisions
5.1 ECOA Coverage, Protected Bases and Application Inquiries 5.2 Age, Spousal Signatures and Joint Credit Intent 5.3 ECOA Action Notices and Specific Reasons
6 6. Valuations and Fair Lending
6.1 Business Credit Notices and Appraisal Delivery 6.2 Fair Lending: Treatment, Effects and Comparative Evidence 6.3 Redlining, Steering and Qualified Self-Tests
7 7. Credit Cards, HELOCs and Open-End Credit
7.1 Credit Cards: Coverage, Disclosures and Ability to Pay 7.2 Credit Card Fees, Payment Allocation and Billing Errors 7.3 HELOCs and general open-end credit
8 8. Closed-End Credit and Mortgage Disclosures
8.1 Closed-End Credit: Disclosures, Finance Charges and APR 8.2 Rescission Timing and Ability-to-Repay Standards 8.3 TRID Integrated Disclosures: Loan Estimate, Closing Disclosure & Fee Tolerances
9 9. Education Loans and Mortgage Insurance
9.1 Private education loan disclosures and cancellation 9.2 Homeowners Protection Act and PMI termination
10 10. HMDA Coverage and Reporting
10.1 HMDA Institutional and Loan Coverage 10.2 HMDA Exclusions, Partial Exemptions and Data Points 10.3 HMDA: Loan Application Register (LAR) Compilation, Demographic Collection & Submission
11 11. Flood Insurance
11.1 Flood Determinations, Notices and Required Coverage 11.2 Flood Contents, Escrow, Private Policies and Force Placement
12 12. CRA Evaluation and Assessment Areas
12.1 CRA Institution Categories and Performance Tests 12.2 Community Development, Ratings and Performance Context 12.3 CRA Assessment Areas and Public File Contents
13 13. CRA Disclosures, Branching and Consumer Protection
13.1 CRA File Deadlines, Notices and Sunshine Agreements 13.2 Interstate banking and branch closing duties 13.3 Unfairness, Deception and Consumer Injury
14 14. UDAAP Controls and Social Media
14.1 Abusiveness and UDAAP Program Controls 14.2 Social media advertising, complaints and records
15 15. BSA Programs, Customers and Currency
15.1 BSA Program Pillars and Independent Testing 15.2 Beneficial Ownership, CIP and Ongoing Due Diligence 15.3 Currency Reports, Aggregation and Exemptions
16 16. Suspicious Activity and Sanctions
16.1 Suspicious Activity Reporting, Confidentiality and Records 16.2 Sanctions Scope, Ownership and Blocking Decisions 16.3 OFAC Reports, Records, Licensing and Screening Controls
17 17. Check Availability and Exception Holds
17.1 Regulation CC Scope, Deposit Days and Next-Day Items 17.2 Initial-Dollar Availability, Ordinary Checks and Policy Disclosures 17.3 Exception Hold Grounds and Reasonable Periods
18 18. Hold Notices and Settlement Services
18.1 Hold Notices, Timing and Consumer Communications 18.2 RESPA Coverage, Referral Payments and Fee Splits 18.3 Permissible Services, Ownership Returns and Marketing Agreements
19 19. Mortgage Servicing
19.1 Escrow, Servicing Errors and Force-Placed Insurance 19.2 Early Intervention, Continuity of Contact and Loss Mitigation
20 20. Consumer Reports and Credit Decisions
20.1 Consumer Reports: Permissible Purpose and Employment Use 20.2 FCRA Adverse Action Notices and Credit Score Disclosures 20.3 Risk-Based Pricing and Furnisher Accuracy Duties
21 21. Furnishing, Medical Information and Identity Theft
21.1 Negative Information Notices and Furnisher Disputes 21.2 Medical information in credit decisions: Regulation FF and V 21.3 Identity Theft Program Scope, Governance and Detection
22 22. Identity Theft and Debt Collection
22.1 Red Flag Responses, Program Updates and Address Validation 22.2 Debt Collector Scope, Calls and Communication Limits 22.3 Electronic Collection Messages and Validation Disputes
23 23. SCRA Protections and MLA Coverage
23.1 SCRA Eligibility and the Six-Percent Interest Cap 23.2 SCRA Foreclosure, Repossession, Leases and Waivers 23.3 MLA Borrowers, Identification and Credit Exemptions
24 24. Military Credit and Consumer Communications
24.1 MAPR, Military Disclosures and Prohibited Credit Terms 24.2 TCPA Calling Technology, Consent and Do-Not-Call Rules 24.3 Telephone Enforcement, TSR Coverage and Commercial Email
25 25. Electronic Consent and Consumer Leasing
25.1 E-SIGN Consent and Consumer Electronic Records 25.2 Consumer Leasing Coverage, Disclosures and Residual Value
26 26. Deposit Insurance and Privacy Notices
26.1 FDIC Insurance: Single, Joint and Trust Ownership 26.2 Retirement, Business and Custodial Insurance; FDIC Signs 26.3 Privacy Notices, Sharing and Opt-Out Opportunities
27 27. Privacy Sharing and Information Security
27.1 Privacy Sharing Exceptions, Account Numbers and Reuse 27.2 Information Security Programs and Incident Investigation 27.3 Customer Incident Notices and Regulatory Notification Clocks
28 28. Authentication and Specialized Data Privacy
28.1 Authentication, access and layered security 28.2 GDPR scope, lawful processing and incident response 28.3 HIPAA and HITECH in bank services
29 29. Insider Lending and Affiliate Definitions
29.1 Regulation O Insider Definitions and Nonpreferential Credit 29.2 Insider Approvals, Lending Limits and Executive Restrictions 29.3 Affiliate Definitions, Covered Transactions and Collateral
30 30. Affiliate Transactions, Appraisals and Originators
30.1 Low-Quality Assets, Market Terms and Affiliate Limits 30.2 Title XI Valuation Thresholds, Exemptions and Credentials 30.3 Valuation Independence, HPML Appraisals and SAFE Registration
31 31. Garnishment and Financial Records
31.1 Federal Benefit Garnishment: Review, Protection and Notice 31.2 Financial Privacy: Government Requests, Certificates and Exceptions 31.3 Regulation S and financial-record reimbursement
32 32. Bank Security and Insurance Sales
32.1 Bank Bribery and Physical Security Programs 32.2 Security Reporting and Retail Nondeposit Investments 32.3 Consumer protection in bank insurance sales
33 33. Securities Activities and Anti-Bribery Rules
33.1 Regulation R and bank brokerage exceptions 33.2 Regulation U purpose credit and margin collateral 33.3 FIRREA civil penalties and foreign bribery risks
34 34. Payment Systems, Child Privacy and Tax Reporting
34.1 Deposit Classification, Reserve Ratios and Debit Interchange 34.2 Internet Gambling Controls, Child Privacy and Email Rules 34.3 IRS information reporting and backup withholding
35 35. Accessible Banking
35.1 ADA Title III and access to banking services
36 36. CMS Governance and Operating Procedures
36.1 Board of Directors & Senior Management Oversight: Responsibilities, Culture & Resources 36.2 The Three Lines of Defense Model in Bank Compliance 36.3 Compliance Policies and Procedures: Development, Approval Cycles & Operationalization
37 37. Compliance Risk Assessment
37.1 Compliance Risk Assessment: Exposure and Control Evidence 37.2 Residual Risk, Specialized Reviews and Event-Driven Updates 37.3 Risk Scoring, Impact Dimensions and Risk Appetite
38 38. Risk Indicators and Compliance Training
38.1 Compliance Indicators, Emerging Risks and Model Limits 38.2 Legal Training Duties and Role-Based Curriculum 38.3 Board Education, Training Administration and Effectiveness
39 39. Monitoring, Testing and Vendor Diligence
39.1 Monitoring, Independent Assurance and Risk-Based Scoping 39.2 Sampling Objectives, Workpapers and Testing Reports 39.3 Third-Party Planning, Diligence and Contract Design
40 40. Vendor Controls and Complaint Management
40.1 Vendor Monitoring, Fintech Controls and Service-Company Notices 40.2 Complaint Intake, Investigation and Root Cause 40.3 Complaint Reporting, Agency Responses and Systemic Redress
41 41. Regulatory Change and Corrective Planning
41.1 Regulatory Surveillance, Impact Assessment and Gap Analysis 41.2 Change Implementation, Validation and Judicial Stays 41.3 Issue Prioritization, Root Cause and Corrective Plan Design
42 42. Restitution and Examination Management
42.1 Remediation Populations, Restitution and Closure Evidence 42.2 Examination Coordination and Consumer Compliance Ratings 42.3 Supervisory Findings, Responses and Enforceable Actions
43 43. Regulatory Reports and Resubmissions
43.1 Regulatory reporting, corrections and examiner updates
21.2 Medical information in credit decisions: Regulation FF and V
Key Takeaways Explain This Topic AI
Medical-information rules distinguish financial account facts from prohibited consideration of health details.
Regulation FF and Regulation V contain specific exceptions and safeguards.
A credit decision should not use a diagnosis merely because medical information appears in a file.
Last updated: October 2026
Identify the FCRA medical-information restriction
The CRCM outline names Regulations V and FF with the Fair Credit Reporting Act. Regulation FF implements the FACT Act’s medical-information restrictions; it is not the name of the bank identity-theft red-flags rule. The current CFPB Regulation V medical-information provisions, including Section 1022.30, provide an important operational starting point. Distinguish these credit-information rules from HIPAA health-service privacy and from a bank’s prudential identity-theft program.
Medical information under FCRA concerns specified information relating to a consumer’s health, treatment or payment for health care. A creditor generally may not obtain or use medical information to determine credit eligibility except as permitted by the statute and regulation. Receipt, use, reporting and affiliate sharing can raise different questions. A bank’s authority to make a credit decision does not mean every health detail is an appropriate underwriting factor.
Financial information versus health judgments
The financial-information exception permits use of qualifying financial information that happens to involve medical debts or expenses under its conditions. The information must be of a type routinely used in credit eligibility, used no less favorably than comparable nonmedical information, and not used to assess the consumer’s physical or mental health, condition, treatment or prognosis. The exception is not permission to predict life expectancy or illness-related employment risk from a treatment record.
For example, the amount of an otherwise permissible financial obligation can be analyzed consistently with similar obligations, subject to current medical-debt restrictions. The lender cannot treat a debt more harshly solely because it arose from a particular diagnosis or treatment. Review both the data field and the decision logic: a financial label can conceal health-based scoring if the model uses provider names or treatment categories to infer prognosis.
Information or practice Initial review question
Financial obligation connected with health care Does a permitted exception and current rule allow its use?
Diagnosis used to predict repayment Is this prohibited health-based eligibility analysis?
Consumer volunteers a treatment record May it be used, despite being received?
Affiliate shares medical information Which distinct statutory restrictions apply?
Model uses provider identity Does it infer medical condition or discriminate?
Unsolicited information and other exceptions
A consumer can provide information a creditor did not seek. Unsolicited receipt does not authorize unrestricted underwriting use. Route it appropriately, determine whether an exception permits its use and avoid including unnecessary details in broadly accessible credit files. A loan officer should not ask for a diagnosis as a shortcut to assessing whether a consumer can repay.
The rule contains other specific exceptions, including particular consumer requests, certain specialized credit arrangements and other defined circumstances. Apply the actual conditions rather than a blanket waiver obtained in every application. A generic consent to obtain a consumer report is not automatically consent to use all medical information for every purpose. When an exception requires a particular consumer request or authorization, preserve evidence supporting that condition.
Reports, coding and affiliate sharing
FCRA limits disclosure of medical information by consumer reporting agencies, with specified conditions and treatment for appropriately coded financial information. It also restricts certain sharing among affiliates. A bank should understand the source, coding and permitted use of report data. The consumer-report permissible-purpose rule and the medical-information exception are separate gates; passing one does not automatically satisfy the other.
Credit policy should address prohibited inputs, permitted financial treatment, manual overrides and model validation. Medical provider identifiers, free-text notes and documents supplied during a hardship request can be sensitive even when not scored. Control access and retention according to applicable requirements and the legitimate purpose. Do not assume GLBA privacy notices authorize an otherwise prohibited FCRA medical-information practice.
Current rule and litigation status
Medical-debt policy has changed through rulemaking and litigation. The CFPB’s January 2025 medical-debt rule was vacated by a federal court in July 2025. Do not present that vacated rule’s categorical restrictions as the operative federal rule. Conversely, the vacatur did not remove every longstanding FCRA medical-information restriction or any independently applicable state law. Review current Section 1022.30, the relevant court order and applicable state requirements when designing a live process.
For an exam scenario, identify the rule date and facts provided. If a loan officer proposes denying credit because a consumer’s medical record suggests future illness, analyze the health-based use rather than equating it with an ordinary financial ratio. If the problem instead describes permitted financial information, apply the exception’s equal-treatment and no-health-inference conditions. These cases can look similar but have different legal outcomes.
Design a focused review
A monitoring scope can compare approved data inputs with actual applications, underwriting notes, model features and adverse-action reasons. Interview staff handling hardship and accommodation requests, since those files can contain unsolicited health information. Validate exceptions with the business unit, document the applicable authority and assess the affected population before determining remediation.
Training should teach employees to distinguish financial capacity, prohibited health inference and permissible accommodation processes. A bank can work with a customer’s request without turning every disclosed disability into an underwriting penalty. Coordinate FCRA, fair lending, privacy and information security rather than reducing the issue to a single form.
Federal Reserve Regulation FF summary and CFPB Section 1022.30 provide the primary concepts and current regulatory text.